Sort by:

select Language:

Field use of molluscicides in schistosomiasis control programmes: an operational manual for programme managers

World Health Organization (WHO), (2017)

Recent systematic reviews and meta-analysis of the impact of chemical-based mollusciciding (King et al., 2015, Sokolow et al., 2016) have concluded that regular mollusciciding is likely to contribute significantly towards elimination of schistosomiasis in high-risk areas. The WHO roadmap’s new focus on “transmission control, wherever possible” (WHO, 2012a) reinforces the need to promote intermediate-host snail control to prevent schistosomiasis transmission.
This operational manual is intended to facilitate the reintroduction of practices and protocols for use of molluscicides in the field in schistosomiasis control programmes. It is complemented by guidelines on the laboratory and field testing of the efficacy of molluscicides for schistosomiasis control (WHO, 2017 [in preparation]).

Conception et validation d’une enquête sur le seul trichiasis trachomateux

Organisation mondiale de la Santé (OMS), Groupe consultatif stratégique et technique sur les maladies tropicales négligées, Groupe de travail du contrôle et de l’évaluation, (2017)

The World Health Organization (WHO) endorses the use of population-based prevalence surveys for estimating the prevalence of trachoma. In general, the prevalence of TF in children aged 1–9 years and the prevalence of TT in adults aged ≥ 15 years are measured at the same time in any district being surveyed. This was the approach of the Global Trachoma Mapping Project, which undertook baseline surveys in > 1500 districts worldwide in order to provide the data required to start interventions where needed.
The survey design recommended by WHO is a two-stage cluster random sample survey, which uses probability proportional to size sampling to select 20–30 villages, and random, systematic or quasi-random sampling to select 25–30 households in each of those villages. In most surveys, everyone aged ≥ 1 year living in selected households is examined.

Generic risk assessment model for insecticide-treated nets, 2nd ed.

World Health Organization (WHO), (2018)

Long-lasting insecticidal nets (LNs) constitute a core vector control intervention against malaria. A number of new LN products are under development and will require assessment of risks to humans. This document provides an updated generic model that can be used for the risk assessment of exposure to insecticides of individuals sleeping under LNs and during the washing of nets.
In an Annex, exposures and health risks are described for the conventional treatment or retreatment of nets (ITNs) with an insecticide considering that such practices may still be used in evaluation of ITNs and their use. The generic model does not include the risks associated with the manufacturing of LNs in a factory environment.

Collaborative framework for addressing Autism Spectrum Disorder in the South-East Asia Region

World Health Organization (WHO), Regional Office for South-East-Asia, (2017)

Based on WHO South-East Asia Regional Strategy on Autism Spectrum Disorder
The collaborative framework for implementation of the “WHO South-East Asia Regional Strategy on Autism Spectrum Disorders” articulates to Member States: the nature of autism spectrum disorder and the issues faced by PwASD and their caregivers; the foundation on which the Regional Strategy and the collaborative framework is based; desired outcomes against each objective of the ASD Regional Strategy; recommended actions to fulfill each objective; requisite parameters that should govern the recommended actions; and suggested guidelines for monitoring, evaluating and reporting a Member State’s progress towards fulfilling the objectives. It encourages Member States to share best practices and information for promoting cooperation and partnerships for development of effective and sustainable programmes.

Global health sector strategy on Sexually Transmitted Infections, 2016-2021: Towards Ending STIs

World Health Organization (WHO), (2016)

The strategy, once adopted, and its implementation will contribute to a radical decline in new sexually transmitted infections and in deaths related to such infections (including still births and cervical cancer), while improving individual health, men’s and women’s sexual health, and the well-being of all people. It will guide efforts to: accelerate and focus comprehensive prevention efforts through scaling up evidence-based combined behavioural, biomedical and structural approaches; facilitate people’s access to information on their sexually transmitted infection status; improve access to treatment and comprehensive long-term care when needed; and challenge pervasive stigmatization and discrimination. The strategy promotes a people-centred approach, grounded in principles of human rights, gender equality and health equity.

Establishing external quality assessment programmes for screening of donated blood for transfusion-transmissible infections: implementation guide

World Health Organization (WHO), (2016)

External quality assessment (EQA) is an important component of quality systems for blood transfusion services. Establishing external quality assessment programmes for screening of donated blood for transfusion-transmissible infections (TTI): implementation guide aims to support WHO member States in establishing and operating EQA programmes for screening donated blood for TTI. The guides has been designed for use by national health authorities and EQA organizing institutions in the development of EQA programme. It will also give participating laboratories an insight into the organization of EQA programmes for TTI screening and an understanding of the benefits of participation.

885 hits